Drug intelligence / Profile preview

gentamicine + diclofenac

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

This is a fixed-dose combination drug containing gentamicin (an aminoglycoside antibiotic) and diclofenac (a nonsteroidal anti-inflammatory drug, NSAID). It is primarily formulated as eye drops for the postoperative management of inflammation and infection following ocular surgery such as cataract extraction. Gentamicin acts by binding to the 30S subunit of bacterial ribosomes, inhibiting protein synthesis and exerting bactericidal effects against a broad range of Gram-negative bacteria. Diclofenac inhibits cyclooxygenase-1 and -2 enzymes (COX-1/COX-2), reducing prostaglandin synthesis responsible for pain, inflammation, and fever. The combination provides both antimicrobial protection against postoperative infections and anti-inflammatory action to control ocular inflammation. Studies have also shown that this combination can exhibit synergistic antibacterial effects in vitro against pathogens like Pseudomonas aeruginosa and Listeria monocytogenes[1][3][5].

Brand names
DR 1352/1
Other names
diclofenac-gentamicindiclofenac and gentamicin sulphate IPdiclofenac sodium + gentamicin
02

Targets

NeuraminidasePTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)Bacterial Ribosome

Beyond the preview

Go deeper on gentamicine + diclofenac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gentamicine + diclofenac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call